Article

Can we safely reduce the administration of 131-iodine in patients with differentiated thyroid cancer? – experience of the Brugmann hospital in Brussels

2020-08-20

Abstract excerpt

<title>Abstract</title> <p>Background 131-iodine (131I) administration after surgery remains a standard practice in differentiated thyroid cancer (DTC). In 2014, the American Thyroid Association presented new guidelines for the staging and management of DTC, including no systematic 131I in patients at low-risk of recurrence and a reduced 131I activity in intermediate risk. The present study aims at evaluating the...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 1b075d74-1d2f-5803-b27c-7eccc68356ff
DOI: 10.21203/rs.3.rs-39339/v2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Can we safely reduce the administration of 131-iodine in patients with differentiated thyroid cancer? – experience of the Brugmann hospital in BrusselsDOI 10.21203/rs.3.rs-39339/v2Read

[What's new in follicular thyroid cancer management in 2014?].Semantic proximity Read

125I seeds implantation for lymph nodes metastasisfrom radioactive iodine-refractory differentiated thyroid carcinoma: A short-term efficacy and dosimetry studySemantic proximity Read

Radiofrequency Ablation for Locoregional Structural Incomplete Response in Differentiated Thyroid Cancer; initial experience in GreeceSemantic proximity Read

Efficacy of Radioiodine in Non-Distant Metastatic Papillary Thyroid Cancer with TERT-p Mutation at Initial DiagnosisSemantic proximity Read

[Modern aspects influencing the management of patients with papillary thyroid cancer].Semantic proximity Read

25I seeds implantation for lymph nodes metastasisfrom radioactive iodine-refractory differentiated thyroid carcinoma: A short-term efficacy and dosimetry studySemantic proximity Read

Medullary Thyroid Cancer: Single Institute Experience Over 3 Decades and Risk Factors for Recurrence.Semantic proximity Read

[Thyroid carcinomas: the role of systemic therapies in internal medicine].Semantic proximity Read

Risk of second primary malignancy after radioiodine for thyroid carcinoma: a SEER-based studySemantic proximity Read

Risk of second primary malignancies following radioactive iodine therapy in thyroid cancer: A meta-analysis of 1,189,992 patientsSemantic proximity Read

Clinical Outcome and Prognosis of Differentiated Thyroid Carcinoma with Distant MetastasisSemantic proximity Read

[Radiation therapy in thyroid cancer].Semantic proximity Read